- Home
- MNKD vs CSIQ Comparison
MNKD vs CSIQ Comparison
Compare MNKD & CSIQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MNKD | CSIQ |
|---|---|---|
| Founded | 1991 | 2001 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 877.0M | 824.4M |
| IPO Year | 2004 | 2006 |
Fundamental Metrics
Financial Performance| Metric | MNKD | CSIQ |
|---|---|---|
| Price | $3.98 | $16.64 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 10 |
| Target Price | $8.69 | ★ $17.36 |
| AVG Volume (30 Days) | ★ 3.3M | 2.5M |
| Earning Date | 05-06-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $348,966,000.00 | N/A |
| Revenue This Year | $35.81 | $23.61 |
| Revenue Next Year | $11.89 | $13.90 |
| P/E Ratio | $142.75 | ★ N/A |
| Revenue Growth | ★ 22.23 | N/A |
| 52 Week Low | $2.23 | $8.93 |
| 52 Week High | $6.51 | $34.59 |
Technical Indicators
Market Signals| Indicator | MNKD | CSIQ |
|---|---|---|
| Relative Strength Index (RSI) | 79.50 | 61.70 |
| Support Level | $3.39 | $15.93 |
| Resistance Level | $6.21 | $17.07 |
| Average True Range (ATR) | 0.18 | 1.11 |
| MACD | 0.11 | 0.48 |
| Stochastic Oscillator | 83.24 | 91.23 |
Price Performance
Historical ComparisonAbout MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.
About CSIQ Canadian Solar Inc. (ON)
Canadian Solar Inc is a Canadian solar technology and renewable energy company. It is a manufacturer of solar photovoltaic modules, a provider of battery energy storage solutions, and a developer of utility-scale solar power and battery energy storage projects.. It operates through two business segments CSI Solar and Recurrent Energy segment. The CSI Solar segment focused on solar modules and battery energy storage manufacturing and products. Its Recurrent segment focused on utility-scale solar power and battery energy storage project development and operation. Key revenue is generated from CSI Solar segment.